Senores Pharmaceuticals Limited (BOM:544319)
India · Delayed Price · Currency is INR 785.40
+10.65 (1.37%)
At close: Apr 2, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 36.12 billion as of April 2, 2026. Its market cap has increased by 41.89% in one year.
Market Cap
36.12B
Enterprise Value
36.71B
Revenue
5.53B
Ranking
n/a
PE Ratio
35.55
Stock Price
785.40
Market Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 36.12B, an increase of 40.79%. That is a compound annual growth rate of 31.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 36.12B | -4.62% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 83.73B |
| Procter & Gamble Health | 79.19B |
| Sanofi India | 75.19B |
| FDC Limited | 54.27B |
| Gufic Biosciences | 29.06B |
| Novartis India | 25.38B |
| Bliss GVS Pharma | 24.79B |
| Unichem Laboratories | 21.01B |